Skip to main content

#161695

Anti-HLA-DR monoclonal antibody [GRB1]

Cat. #161695

Anti-HLA-DR monoclonal antibody [GRB1]

Cat. #: 161695

Sub-type: Primary antibody

Availability: 3-4 weeks

Target: HLA-DR

Class: Monoclonal

Application: FACS; IHC; ELISA; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot, Federico Garrido Torres-Puchol

Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service

Primary Citation: Ruiz-Cabello. 1985. Sangre (Barc). 30(2):190-196. PMID: 3859940

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-HLA-DR monoclonal antibody [GRB1]
  • Cancer: Blood cancer
  • Research fields: Cancer
  • Clone: GRB1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Molecular weight: 35 kDa & 33 kDa (68 kDa; heterodimer)
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS; IHC; ELISA; WB
  • Description: HLA-DR antigen is composed of an alpha-beta heterodimer of 35 and 33 Kd respectively. It is highly polymorphic in the human population. GRB1 recognises an epitope shared by all HLA-DR alleles. It is expressed in antigen presenting cells: dendritic cells, macrophages and B lymphocytes and in some tumours
  • Immunogen: B-ALL cells
  • Isotype: IgG2ak
  • Recommended controls: leukocytes

Target Details

  • Target: HLA-DR
  • Molecular weight: 35 kDa & 33 kDa (68 kDa; heterodimer)

Applications

  • Application: FACS; IHC; ELISA; WB

Handling

  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Ruiz-Cabello. 1985. Sangre (Barc). 30(2):190-196. PMID: 3859940

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.